Neurosurgeon Dr. Keith Black

The Neurosurgeon discusses early detection and the development of a groundbreaking new test that can identify signs of Alzheimer’s disease.

The research of Keith L Black, MD, focuses on biology of blood-brain barrier (BBB) and biochemical modulation of the blood-brain tumor barrier (BTB), targeted drug delivery, tumor immunology, cancer vaccines, cancer stem cells, microwave tumor ablation, nanotechnology for drug delivery, optical guided surgery for brain tumors, and Alzheimer's retinal imaging.
Last modified: June 9, 2017 at 1:21 pm